BIO Debt-to-Equity Ratio Analysis
Higher than 48% of Healthcare sector peers
Updated 413h ago·SEC filings & market data
Key Takeaway
The debt-to-equity ratio divides total liabilities by shareholder equity, showing how much debt a company uses to fund its assets relative to owner capital.
Sector Performance
48th percentileBIO
0.17x
Sector Median
0.26x
Sector Avg
0.89x
Prior Period
0.18x(Jul 2026)
Deep Analysis
The debt-to-equity ratio divides total liabilities by shareholder equity, showing how much debt a company uses to fund its assets relative to owner capital.
A 0.17x current value means Bio-Rad holds $0.17 of debt for every $1 of equity, indicating low financial leverage. This is below the healthcare sector median of 0.45x, placing the company at the 44th percentile among peers, so it carries less debt than most but not the least. The year-over-year change is N/A, while the quarter-over-quarter change is -5.6%, reflecting a decline from 0.18x to 0.17x in the most recent period. A low and falling ratio suggests the company is reducing debt or increasing equity, which lowers financial risk and can be seen as a defensive quality. That combination supports a neutral view: leverage is conservative, but the moderate percentile shows no standout advantage. The metric therefore directly supports the overall NEUTRAL verdict rather than contradicting it.
Frequently Asked Questions
What does the Debt-to-Equity Ratio tell investors about BIO?
Shows how much a company is financing its operations through debt vs shareholder funds. High D/E can amplify returns — and losses.
How is the Debt-to-Equity Ratio calculated?
Debt-to-Equity Ratio is calculated as: Total Debt / Shareholders' Equity.
How does BIO's Debt-to-Equity Ratio compare to its sector?
BIO's Debt-to-Equity Ratio of 0.17x compares to a Healthcare sector median of 0.26x, placing it in the 48th percentile.
Who are BIO's closest peers by Debt-to-Equity Ratio?
The closest Healthcare peers by Debt-to-Equity Ratio include: BIIB (0.34x), NTLA (0.13x), TECH (0.10x), BEAM (0.09x), RVTY (0.45x).
Learn More About Debt-to-Equity Ratio
How to Spot a Debt Problem Before It Hits the Stock Price
Learn how to spot a debt problem in stocks using D/E, interest coverage, and net debt/EBITDA ratios. Real examples from META and MSFT, plus danger thresholds you need to know.
Debt/Equity Ratio: How Much Debt Is Too Much?
The debt to equity ratio explained: why context, interest coverage, and sector norms matter far more than the raw number when assessing debt risk.
The Formula
Total Debt / Shareholders' Equity
Why It Matters
Shows how much a company is financing its operations through debt vs shareholder funds. High D/E can amplify returns — and losses.
Master BIO's Valuation
Get the complete institutional research report covering all fundamental and technical metrics.
View full BIO research report →BIO
0.17x
Sector Median
0.26x
Sector Avg
0.89x
How BIO's Debt-to-Equity Ratio compares to sector peers.
Also Analyze
Not financial advice. Research tool only. Data may be delayed.